{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:12:24Z","timestamp":1792714344169,"version":"4.5.0"},"reference-count":65,"publisher":"American Association for Cancer Research (AACR)","issue":"10","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001784","name":"Pancreatic Cancer Action Network","doi-asserted-by":"publisher","award":["22-20-HOBB"],"award-info":[{"award-number":["22-20-HOBB"]}],"id":[{"id":"10.13039\/100001784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001558","name":"Concern Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001558","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["1I01BX002095"],"award-info":[{"award-number":["1I01BX002095"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20 GM130457"],"award-info":[{"award-number":["P20 GM130457"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P20 GM123456"],"award-info":[{"award-number":["P20 GM123456"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA212608"],"award-info":[{"award-number":["R01CA212608"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM148302"],"award-info":[{"award-number":["P20GM148302"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30DK123704"],"award-info":[{"award-number":["P30DK123704"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["S10 OD010731"],"award-info":[{"award-number":["S10 OD010731"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA138313"],"award-info":[{"award-number":["P30CA138313"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1R01CA276771"],"award-info":[{"award-number":["1R01CA276771"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["IRG #19-138-34"],"award-info":[{"award-number":["IRG #19-138-34"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008980","name":"Medical College of Wisconsin","doi-asserted-by":"publisher","award":["Dept. of Surgery We Care Fund"],"award-info":[{"award-number":["Dept. of Surgery We Care Fund"]}],"id":[{"id":"10.13039\/100008980","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001437","name":"Abney Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001437","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>The RAS family of small GTPases is among the most frequently mutated gene families in human cancer. In pancreatic ductal adenocarcinoma (PDAC), \u223c95% of cases harbor an activating KRAS mutation, primarily at codon 12, 13, or 61, with G12D being the most common overall (40%). In contrast, the KRASQ61L mutation, though constitutively active, is virtually absent in tumors of patients with PDAC. This suggests that KRASQ61L may engage in distinct, allele-specific signaling that limits its ability to drive tumorigenesis. Determining the mechanisms that limit the occurrence of this mutation will aid in our understanding of the critical KRAS effectors and pathways that drive tumorigenesis. To investigate these mechanisms, we utilized a tightly controlled doxycycline-inducible KRAS expression system in an isogenic, immortalized pancreatic cell line, enabling direct comparison of KRASQ61L with the common PDAC mutant KRASG12D. Using TurboID proximity labeling alongside RNA sequencing, we mapped early effector interactions and transcriptional responses, revealing that KRASQ61L induces greater hyperactivation of the ERK\/MAPK pathway, resulting in increased nuclear translocation of ERK1\/2. Finally, pancreatic cells are highly tolerant to overexpression of KRASG12D, but KRASQ61L overexpression leads to impaired proliferation and increased apoptosis. These findings provide experimental support for the long-standing \u201cGoldilocks\u201d model of oncogenic signaling, in which too much ERK\/MAPK pathway activation is detrimental to tumorigenesis. Our work offers a mechanistic explanation for the relative absence of KRASQ61L in PDAC and contributes to our understanding of KRAS allele\u2013specific vulnerabilities, which can inform future therapeutic strategies targeting KRAS-driven pancreatic cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>This study demonstrates that KRASQ61L drives hyperactivation of ERK\/MAPK signaling and triggers apoptosis, which limits the proliferation of pancreatic cells. These findings support a \u201cGoldilocks\u201d model of RAS signaling and suggest that strong hyperactivation of the ERK\/MAPK pathway contributes to the selective absence of KRASQ61L in pancreatic tumorigenesis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-25-0281","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T11:36:59Z","timestamp":1757936219000},"page":"1865-1878","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pancreatic Cells Are Resistant to KRASQ61L Expression due to Hyperactive ERK\/MAPK Signaling and Apoptosis Induction"],"prefix":"10.1158","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9363-4333","authenticated-orcid":false,"given":"Rachel A.","family":"Burge","sequence":"first","affiliation":[{"name":"1Department of Biochemistry & Molecular Biology, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1126-8670","authenticated-orcid":false,"given":"Lucas","family":"Bialousow","sequence":"additional","affiliation":[{"name":"1Department of Biochemistry & Molecular Biology, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5284-6994","authenticated-orcid":false,"given":"Thomas","family":"McFall","sequence":"additional","affiliation":[{"name":"2Department of Biochemistry and MCW Cancer Center, Medical College of Wisconsin, Milwaukee, Wisconsin."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2092-4778","authenticated-orcid":false,"given":"Logan","family":"Bamonte","sequence":"additional","affiliation":[{"name":"1Department of Biochemistry & Molecular Biology, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9372-6835","authenticated-orcid":false,"given":"Grayson","family":"Johnson","sequence":"additional","affiliation":[{"name":"1Department of Biochemistry & Molecular Biology, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3298-2543","authenticated-orcid":false,"given":"Merissa","family":"Smith","sequence":"additional","affiliation":[{"name":"3College of Graduate Studies, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5811-1659","authenticated-orcid":false,"given":"Silvia G.","family":"Vaena","sequence":"additional","affiliation":[{"name":"4Bioinformatics Core, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8479-6695","authenticated-orcid":false,"given":"Susana","family":"Comte-Walters","sequence":"additional","affiliation":[{"name":"5Department of Pharmacology and Immunology, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6780-1679","authenticated-orcid":false,"given":"Lauren E.","family":"Ball","sequence":"additional","affiliation":[{"name":"5Department of Pharmacology and Immunology, Medical University of South Carolina, Charleston, South Carolina."},{"name":"7Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9028-9458","authenticated-orcid":false,"given":"Stefano","family":"Berto","sequence":"additional","affiliation":[{"name":"4Bioinformatics Core, Medical University of South Carolina, Charleston, South Carolina."},{"name":"6Department of Neuroscience, Medical University of South Carolina, Charleston, South Carolina."},{"name":"7Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5386-1080","authenticated-orcid":false,"given":"John P.","family":"O\u2019Bryan","sequence":"additional","affiliation":[{"name":"1Department of Biochemistry & Molecular Biology, Medical University of South Carolina, Charleston, South Carolina."},{"name":"7Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4751-9681","authenticated-orcid":false,"given":"G. Aaron","family":"Hobbs","sequence":"additional","affiliation":[{"name":"1Department of Biochemistry & Molecular Biology, Medical University of South Carolina, Charleston, South Carolina."},{"name":"7Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"2025102203080097200_bib1","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1126\/science.1164368","article-title":"Core signaling pathways in human pancreatic cancers revealed by global genomic analyses","volume":"321","author":"Jones","year":"2008","journal-title":"Science"},{"key":"2025102203080097200_bib2","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-11-2612","article-title":"A comprehensive survey of Ras mutations in cancer","volume":"72","author":"Prior","year":"2012","journal-title":"Cancer Res"},{"key":"2025102203080097200_bib3","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"2025102203080097200_bib4","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1126\/science.1145720","article-title":"The genomic landscapes of human breast and colorectal cancers","volume":"318","author":"Wood","year":"2007","journal-title":"Science"},{"key":"2025102203080097200_bib5","doi-asserted-by":"crossref","first-page":"a031435","DOI":"10.1101\/cshperspect.a031435","article-title":"KRAS: the critical driver and therapeutic target for pancreatic cancer","volume":"8","author":"Waters","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2025102203080097200_bib6","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1242\/jcs.182873","article-title":"RAS isoforms and mutations in cancer at a glance","volume":"129","author":"Hobbs","year":"2016","journal-title":"J Cell Sci"},{"key":"2025102203080097200_bib7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jtho.2022.11.030","article-title":"Tobacco smoking-related mutational signatures in classifying smoking-associated and nonsmoking-associated NSCLC","volume":"18","author":"Ernst","year":"2023","journal-title":"J Thorac Oncol"},{"key":"2025102203080097200_bib8","first-page":"100","article-title":"RAS mutations and oncogenesis: not all RAS mutations are created equally","volume":"2","author":"Miller","year":"2011","journal-title":"Front Genet"},{"key":"2025102203080097200_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/bs.acr.2021.07.004","article-title":"Not all RAS mutations are equal: a detailed review of the functional diversity of RAS hot spot mutations","volume":"153","author":"Burge","year":"2022","journal-title":"Adv Cancer Res"},{"key":"2025102203080097200_bib10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1158\/2159-8290.CD-19-1006","article-title":"Atypical KRASG12R mutant is impaired in PI3K signaling and macropinocytosis in pancreatic cancer","volume":"10","author":"Hobbs","year":"2020","journal-title":"Cancer Discov"},{"key":"2025102203080097200_bib11","doi-asserted-by":"crossref","first-page":"e75715","DOI":"10.7554\/eLife.75715","article-title":"Genetically manipulating endogenous Kras levels and oncogenic mutations in vivo influences tissue patterning of murine tumorigenesis","volume":"11","author":"Le Roux","year":"2022","journal-title":"Elife"},{"key":"2025102203080097200_bib12","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1158\/2159-8290.CD-18-1220","article-title":"Tissue-specific oncogenic activity of KRASA146T","volume":"9","author":"Poulin","year":"2019","journal-title":"Cancer Discov"},{"key":"2025102203080097200_bib13","doi-asserted-by":"crossref","first-page":"22122","DOI":"10.1073\/pnas.1908353116","article-title":"KRAS G13D sensitivity to neurofibromin-mediated GTP hydrolysis","volume":"116","author":"Rabara","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025102203080097200_bib14","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1158\/2159-8290.CD-20-0442","article-title":"An in vivo kras allelic series reveals distinct phenotypes of common oncogenic variants","volume":"10","author":"Zafra","year":"2020","journal-title":"Cancer Discov"},{"key":"2025102203080097200_bib65","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41586-024-07359-3","article-title":"3D genomic mapping reveals multifocality of human pancreatic precancers","volume":"629","author":"Braxton","year":"2024","journal-title":"Nature"},{"key":"2025102203080097200_bib15","doi-asserted-by":"crossref","first-page":"eabn2694","DOI":"10.1126\/scisignal.abn2694","article-title":"Functional and biological heterogeneity of KRASQ61 mutations","volume":"15","author":"Huynh","year":"2022","journal-title":"Sci Signal"},{"key":"2025102203080097200_bib16","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1158\/2159-8290.CD-24-0614","article-title":"Direct inhibition of RAS reveals the features of oncogenic signaling driven by RAS G12 and Q61 mutations","volume":"15","author":"Marasco","year":"2025","journal-title":"Cancer Discov"},{"key":"2025102203080097200_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ccell.2015.11.011","article-title":"Long-term ERK inhibition in KRAS-mutant pancreatic cancer is associated with MYC degradation and senescence-like growth suppression","volume":"29","author":"Hayes","year":"2016","journal-title":"Cancer Cell"},{"key":"2025102203080097200_bib18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/BST20200507","article-title":"The ERK mitogen-activated protein kinase signaling network: the final frontier in RAS signal transduction","volume":"49","author":"Klomp","year":"2021","journal-title":"Biochem Soc Trans"},{"key":"2025102203080097200_bib19","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/emboj.2010.7","article-title":"Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival","volume":"29","author":"Drosten","year":"2010","journal-title":"EMBO J"},{"key":"2025102203080097200_bib20","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1158\/0008-5472.CAN-06-3752","article-title":"K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling","volume":"67","author":"Campbell","year":"2007","journal-title":"Cancer Res"},{"key":"2025102203080097200_bib21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/978-1-4939-9546-2_15","article-title":"BioID as a tool for protein-proximity labeling in living cells","volume":"2012","author":"Sears","year":"2019","journal-title":"Methods Mol Biol"},{"key":"2025102203080097200_bib22","doi-asserted-by":"crossref","first-page":"e9370","DOI":"10.15252\/msb.20199370","article-title":"Protease-resistant streptavidin for interaction proteomics","volume":"16","author":"Rafiee","year":"2020","journal-title":"Mol Syst Biol"},{"key":"2025102203080097200_bib23","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1097\/01.MP.0000087422.24733.62","article-title":"Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma","volume":"16","author":"Andea","year":"2003","journal-title":"Mod Pathol"},{"key":"2025102203080097200_bib24","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1053\/j.gastro.2011.12.042","article-title":"Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia","volume":"142","author":"Kanda","year":"2012","journal-title":"Gastroenterology"},{"key":"2025102203080097200_bib25","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/MPA.0000000000000786","article-title":"The prevalence and clinicopathological characteristics of high-grade pancreatic intraepithelial neoplasia: autopsy study evaluating the entire pancreatic parenchyma","volume":"46","author":"Matsuda","year":"2017","journal-title":"Pancreas"},{"key":"2025102203080097200_bib26","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41587-019-0355-0","article-title":"Author Correction: efficient proximity labeling in living cells and organisms with TurboID","volume":"38","author":"Branon","year":"2020","journal-title":"Nat Biotechnol"},{"key":"2025102203080097200_bib27","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1038\/s41467-018-05692-6","article-title":"Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability","volume":"9","author":"Adhikari","year":"2018","journal-title":"Nat Commun"},{"key":"2025102203080097200_bib28","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1158\/2159-8290.CD-19-1274","article-title":"Combined proteomic and genetic interaction mapping reveals new RAS effector pathways and susceptibilities","volume":"10","author":"Kelly","year":"2020","journal-title":"Cancer Discov"},{"key":"2025102203080097200_bib29","doi-asserted-by":"crossref","first-page":"115087","DOI":"10.1016\/j.celrep.2024.115087","article-title":"The differential interactomes of the KRAS splice variants identify BIRC6 as a ubiquitin ligase for KRAS4A","volume":"44","author":"Kochen Rossi","year":"2025","journal-title":"Cell Rep"},{"key":"2025102203080097200_bib30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.trecan.2020.02.002","article-title":"The mystery of Rap1 suppression of oncogenic ras","volume":"6","author":"Nussinov","year":"2020","journal-title":"Trends Cancer"},{"key":"2025102203080097200_bib31","doi-asserted-by":"crossref","first-page":"635518","DOI":"10.3389\/fcell.2021.635518","article-title":"ER-PM contact sites - SNARING actors in emerging functions","volume":"9","author":"Hewlett","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2025102203080097200_bib32","doi-asserted-by":"crossref","first-page":"7698","DOI":"10.1073\/pnas.1002968107","article-title":"Transient tether between the SRP RNA and SRP receptor ensures efficient cargo delivery during cotranslational protein targeting","volume":"107","author":"Shen","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025102203080097200_bib33","doi-asserted-by":"crossref","first-page":"41131","DOI":"10.1074\/jbc.M402902200","article-title":"Nucling recruits Apaf-1\/pro-caspase-9 complex for the induction of stress-induced apoptosis","volume":"279","author":"Sakai","year":"2004","journal-title":"J Biol Chem"},{"key":"2025102203080097200_bib34","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1038\/s41467-022-30881-9","article-title":"Enhanced BRAF engagement by NRAS mutants capable of promoting melanoma initiation","volume":"13","author":"Murphy","year":"2022","journal-title":"Nat Commun"},{"key":"2025102203080097200_bib35","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.molcel.2019.09.004","article-title":"Distinct binding preferences between Ras and Raf family members and the impact on oncogenic Ras signaling","volume":"76","author":"Terrell","year":"2019","journal-title":"Mol Cell"},{"key":"2025102203080097200_bib36","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.ccell.2024.08.002","article-title":"Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer","volume":"42","author":"McIntyre","year":"2024","journal-title":"Cancer Cell"},{"key":"2025102203080097200_bib37","doi-asserted-by":"crossref","first-page":"eadk0775","DOI":"10.1126\/science.adk0775","article-title":"Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers","volume":"384","author":"Klomp","year":"2024","journal-title":"Science"},{"key":"2025102203080097200_bib38","doi-asserted-by":"crossref","first-page":"eadk0850","DOI":"10.1126\/science.adk0850","article-title":"Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer","volume":"384","author":"Klomp","year":"2024","journal-title":"Science"},{"key":"2025102203080097200_bib39","doi-asserted-by":"crossref","first-page":"366","DOI":"10.33594\/000000144","article-title":"Nuclear ERK translocation is mediated by protein kinase CK2 and accelerated by autophosphorylation","volume":"53","author":"Plotnikov","year":"2019","journal-title":"Cell Physiol Biochem"},{"key":"2025102203080097200_bib40","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1158\/1541-7786.MCR-18-0327","article-title":"Hyperactivation of MAPK signaling is deleterious to RAS\/RAF-mutant melanoma","volume":"17","author":"Leung","year":"2019","journal-title":"Mol Cancer Res"},{"key":"2025102203080097200_bib41","doi-asserted-by":"crossref","first-page":"113017","DOI":"10.1016\/j.celrep.2023.113017","article-title":"Negative feedback regulation of MAPK signaling is an important driver of chronic lymphocytic leukemia progression","volume":"42","author":"Ecker","year":"2023","journal-title":"Cell Rep"},{"key":"2025102203080097200_bib42","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41591-024-03362-3","article-title":"Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival","volume":"31","author":"Varghese","year":"2025","journal-title":"Nat Med"},{"key":"2025102203080097200_bib43","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/oncolo\/oyac179","article-title":"KRAS mutation variants and co-occurring PI3K pathway alterations impact survival for patients with pancreatic ductal adenocarcinomas","volume":"27","author":"Diehl","year":"2022","journal-title":"Oncologist"},{"key":"2025102203080097200_bib44","doi-asserted-by":"crossref","first-page":"110096","DOI":"10.1016\/j.celrep.2021.110096","article-title":"Identification of RAS mutant biomarkers for EGFR inhibitor sensitivity using a systems biochemical approach","volume":"37","author":"McFall","year":"2021","journal-title":"Cell Rep"},{"key":"2025102203080097200_bib45","doi-asserted-by":"crossref","first-page":"7095","DOI":"10.3390\/ijms23137095","article-title":"Thermal shift assay for small GTPase stability screening: evaluation and suitability","volume":"23","author":"Kopra","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2025102203080097200_bib46","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1233606","article-title":"Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay","volume":"341","author":"Martinez Molina","year":"2013","journal-title":"Science"},{"key":"2025102203080097200_bib47","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1038\/s41598-019-38822-1","article-title":"KRAS genotyping by digital PCR combined with melting curve analysis","volume":"9","author":"Tanaka","year":"2019","journal-title":"Sci Rep"},{"key":"2025102203080097200_bib48","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1038\/s41467-021-22125-z","article-title":"The origins and genetic interactions of KRAS mutations are allele- and tissue-specific","volume":"12","author":"Cook","year":"2021","journal-title":"Nat Commun"},{"key":"2025102203080097200_bib49","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.molcel.2018.12.001","article-title":"The functional proximal proteome of oncogenic ras includes mTORC2","volume":"73","author":"Kovalski","year":"2019","journal-title":"Mol Cell"},{"key":"2025102203080097200_bib50","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1038\/s43018-024-00847-5","article-title":"The pro-oncogenic noncanonical activity of a RAS*GTP:RanGAP1 complex facilitates nuclear protein export","volume":"5","author":"Tripathi","year":"2024","journal-title":"Nat Cancer"},{"key":"2025102203080097200_bib51","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1101\/gad.1158803","article-title":"Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs","volume":"17","author":"Yi","year":"2003","journal-title":"Genes Dev"},{"key":"2025102203080097200_bib52","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41586-023-06123-3","article-title":"Pan-KRAS inhibitor disables oncogenic signalling and tumour growth","volume":"619","author":"Kim","year":"2023","journal-title":"Nature"},{"key":"2025102203080097200_bib53","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3389\/fonc.2019.01088","article-title":"A comparative analysis of individual RAS mutations in cancer biology","volume":"9","author":"Mu\u00f1oz-Maldonado","year":"2019","journal-title":"Front Oncol"},{"key":"2025102203080097200_bib54","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1158\/2159-8290.CD-20-0142","article-title":"BI-3406, a potent and selective SOS1-KRAS interaction inhibitor, is effective in KRAS-driven cancers through combined MEK inhibition","volume":"11","author":"Hofmann","year":"2021","journal-title":"Cancer Discov"},{"key":"2025102203080097200_bib55","doi-asserted-by":"crossref","first-page":"6274","DOI":"10.1038\/s41467-021-26526-y","article-title":"The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors","volume":"12","author":"Gebregiworgis","year":"2021","journal-title":"Nat Commun"},{"key":"2025102203080097200_bib56","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1158\/2159-8290.CD-14-0729","article-title":"Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma","volume":"4","author":"Burd","year":"2014","journal-title":"Cancer Discov"},{"key":"2025102203080097200_bib57","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1073\/pnas.1218173110","article-title":"NMR-based functional profiling of RASopathies and oncogenic RAS mutations","volume":"110","author":"Smith","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025102203080097200_bib58","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1182\/blood-2018-09-874107","article-title":"Unique dependence on Sos1 in KrasG12D -induced leukemogenesis","volume":"132","author":"You","year":"2018","journal-title":"Blood"},{"key":"2025102203080097200_bib59","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/ncomms2173","article-title":"Sos-mediated cross-activation of wild-type Ras by oncogenic Ras is essential for tumorigenesis","volume":"3","author":"Jeng","year":"2012","journal-title":"Nat Commun"},{"key":"2025102203080097200_bib60","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1038\/onc.2012.404","article-title":"Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis","volume":"32","author":"To","year":"2013","journal-title":"Oncogene"},{"key":"2025102203080097200_bib61","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.semcdb.2016.07.012","article-title":"The role of wild type RAS isoforms in cancer","volume":"58","author":"Zhou","year":"2016","journal-title":"Semin Cell Dev Biol"},{"key":"2025102203080097200_bib62","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41698-024-00554-5","article-title":"ERK pathway agonism for cancer therapy: evidence, insights, and a target discovery framework","volume":"8","author":"Timofeev","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"2025102203080097200_bib63","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.3390\/cells10102509","article-title":"ERK: a double-edged sword in cancer. ERK-dependent apoptosis as a potential therapeutic strategy for cancer","volume":"10","author":"Sugiura","year":"2021","journal-title":"Cells"},{"key":"2025102203080097200_bib64","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3892\/ol.2020.11684","article-title":"Dual effects of active ERK in cancer: a potential target for enhancing radiosensitivity","volume":"20","author":"Lu","year":"2020","journal-title":"Oncol Lett"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-25-0281\/3650885\/crc-25-0281.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/10\/1865\/3662028\/crc-25-0281.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/10\/1865\/3662028\/crc-25-0281.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:08:13Z","timestamp":1761116893000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/5\/10\/1865\/766776\/Pancreatic-Cells-Are-Resistant-to-KRASQ61L"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":65,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-25-0281","relation":{},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]}}}